Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation - PubMed (original) (raw)
Comparative Study
. 1988 May;71(5):1234-43.
Affiliations
- PMID: 2833957
Free article
Comparative Study
Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation
R S Shapiro et al. Blood. 1988 May.
Free article
Abstract
B cell lymphoproliferative disorders (BLPD) developed in eight patients following bone marrow transplantation (BMT) for leukemia (five patients) or immunodeficiency (three patients). Recipients of T depleted marrow from a mismatched donor were at particularly high risk of this complication. Six of 25 (24%) recipients of mismatched T depleted bone marrow developed BLPD. In contrast, none of 47 matched T depleted transplants, one of ten (10%) who received non-depleted marrow from an unrelated donor, and only one of 424 matched non-depleted transplants were associated with BLPD. Epstein-Barr virus (EBV) specific serology and DNA hybridization studies demonstrating five to 50 copies of EBV genome/cell in involved tissues implicate this virus as an associated etiologic agent. Restriction fragment length polymorphism (RFLP) and cytogenetic analysis of involved tissue demonstrated donor origin (five of seven) or host origin (two of seven). Histologic appearance was similar to EBV-induced polymorphic B cell proliferations described following solid organ transplantation, or which occur de novo in primary immunodeficiency. Six of seven patients with adequate tissue available for study were found to have monoclonal proliferations by: in situ immunofluorescence (six of seven), and/or immunoglobulin gene rearrangement, (four of six). Cytogenetic analysis of involved tissues from four patients showed a normal karyotype, whereas two had multiple clonal chromosomal abnormalities. Seven patients died despite aggressive attempts at therapy with combinations of antiviral, immunologic, and chemotherapeutic agents.
Similar articles
- Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients. A clinical, immunobiological and pathological study.
Simon M, Bartram CR, Friedrich W, Arnold R, Schmeiser T, Hampl W, Müller-Hermelink HK, Heymer B. Simon M, et al. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;60(5):307-19. doi: 10.1007/BF02899562. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991. PMID: 1685038 - Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.
Gustafsson A, Levitsky V, Zou JZ, Frisan T, Dalianis T, Ljungman P, Ringden O, Winiarski J, Ernberg I, Masucci MG. Gustafsson A, et al. Blood. 2000 Feb 1;95(3):807-14. Blood. 2000. PMID: 10648390 - Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, et al. Papadopoulos EB, et al. N Engl J Med. 1994 Apr 28;330(17):1185-91. doi: 10.1056/NEJM199404283301703. N Engl J Med. 1994. PMID: 8093146 - B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome.
Gross TG, Steinbuch M, DeFor T, Shapiro RS, McGlave P, Ramsay NK, Wagner JE, Filipovich AH. Gross TG, et al. Bone Marrow Transplant. 1999 Feb;23(3):251-8. doi: 10.1038/sj.bmt.1701554. Bone Marrow Transplant. 1999. PMID: 10084256 Free PMC article. Review. - Therapy for transplant-related lymphoproliferative diseases.
Benkerrou M, Durandy A, Fischer A. Benkerrou M, et al. Hematol Oncol Clin North Am. 1993 Apr;7(2):467-75. Hematol Oncol Clin North Am. 1993. PMID: 8385662 Review.
Cited by
- Admissions for posttransplant lymphoproliferative disorder: a 9-year longitudinal analysis of the National (Nationwide) Inpatient Sample.
El-Amir Z, Jamil A, Solanki D, Mansuri U, Mathew M, Singh J, Aslam S, Akram H, Mandal S, Kichloo A. El-Amir Z, et al. Proc (Bayl Univ Med Cent). 2024 Jul 11;37(5):804-812. doi: 10.1080/08998280.2024.2375688. eCollection 2024. Proc (Bayl Univ Med Cent). 2024. PMID: 39165820 Free PMC article. - Clinical characteristics and outcomes of Epstein-Barr virus viral load after allogeneic hematopoietic stem cell transplantation.
Tsushima T, Masuda SI, Yoda N, Kainuma S, Kimeda C, Konno S, Tanaka K, Matsuo K, Shimoji S, Kimura K, Arai H, Utsu Y, Imadome KI, Aotsuka N. Tsushima T, et al. Ann Hematol. 2024 Mar;103(3):935-946. doi: 10.1007/s00277-023-05596-6. Epub 2023 Dec 29. Ann Hematol. 2024. PMID: 38157001 Free PMC article. - Epstein-Barr virus induced acute hepatitis with hyperferritinemia: A rare presentation.
Theodory B, Dopp M, Swisher AR, Flores RM, Robb PM. Theodory B, et al. IDCases. 2023 Aug 9;33:e01872. doi: 10.1016/j.idcr.2023.e01872. eCollection 2023. IDCases. 2023. PMID: 37609447 Free PMC article. - Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction.
Cai J, Zhang B, Li Y, Zhu W, Akihisa T, Li W, Kikuchi T, Liu W, Feng F, Zhang J. Cai J, et al. Vaccines (Basel). 2021 Nov 7;9(11):1290. doi: 10.3390/vaccines9111290. Vaccines (Basel). 2021. PMID: 34835222 Free PMC article. Review. - Validation of a Post-Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database.
Lee CC, Hsu TC, Kuo CC, Liu MA, Abdelfattah AM, Chang CN, Yao M, Li CC, Wu KH, Chen TC, Gau JP, Wang PN, Liu YC, Chiou LW, Lee MY, Li SS, Chao TY, Jou ST, Chang HH. Lee CC, et al. Oncologist. 2021 Nov;26(11):e2034-e2041. doi: 10.1002/onco.13969. Epub 2021 Sep 23. Oncologist. 2021. PMID: 34506688 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical